Picture this: Five years ago, Electromed $ELMD stock traded around $10.61 per share. Today, it closes at $23.28 — a strong +119% increase. The chart shows a gradual build with acceleration in recent years, supported by demand for respiratory and medical devices.

The 52-week high reached $30.73, showing potential for further upside in positive conditions.

Keeping it simple: The compound annual growth rate (CAGR) is about 17%. If this pace holds, it means solid yearly growth that compounds over time.

Now imagine dollar-cost averaging (DCA): adding $500 every month for the next five years. This adds up to $30,000 from your pocket over 60 months. You buy more shares on dips and fewer on rises, balancing your costs.

If ELMD keeps a similar historical pace around 17% annual growth, your contributions could grow the total to about $46,800 by the end of five years. That means a gain of roughly $16,800 beyond your investment — a solid 56% overall return from consistent investing.

Build your portfolio, one day at a time.
Get our daily 5-year horizon picks sent to your inbox. Subscribe here.

Past performance doesn't guarantee the future — medical device trends, competition, or regulations can change things. But ELMD focuses on specialized respiratory care products with growing needs in patient health. Your $500 monthly plan is simple to follow, letting compounding build steadily.

Rising awareness of respiratory health keeps creating opportunities here. Staying disciplined during any quieter times usually leads to good long-term results.

Ready to grow with this approach?